21.07.2011 • News • AkzoNobel • Q2 2011 • sales and profits

AkzoNobel Q2 Profit Flat

AkzoNobel reported that its second-quarter profit from continuing operations was almost flat at €273 million. Earnings per share from continuing operations were €1.07 compared to €1.05 in the previous year quarter.

Net income for the period was €268 million, lower than €273 million in the prior year quarter. Earnings per share from total operations decreased to €1.14 from €1.16 in the same quarter last year.

Adjusted net income for continuing operations was €256 million, compared to €275 million in the same period last year. Adjusted earnings per share for the quarter were 1.09, down from €1.18 in the previous year quarter.

Quarterly revenue rose 5% to €4.1 billion from €3.91 billion last year, driven by volume and price.

Looking ahead, Akzo Nobel expects full-year EBITDA to be at least in line with the prior year, assuming no further deterioration in economic conditions.

Company

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.